MedPath
FDA Approval

SUPREP Bowel Prep

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 18, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Potassium sulfate(2.35 g in 133.1 mL)
Sodium sulfate(13.13 g in 133.1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

BrainTree Laboratories, Inc.

Braintree Laboratories, Inc.

617357954

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SUPREP Bowel Prep

Product Details

NDC Product Code
52268-112
Application Number
NDA022372
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
August 18, 2020
SUCRALOSEInactive
Code: 96K6UQ3ZD4Class: IACT
MALIC ACIDInactive
Code: 817L1N4CKPClass: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
Code: 1K573LC5TVClass: ACTIBQuantity: 2.35 g in 133.1 mL
Code: 0YPR65R21JClass: ACTIBQuantity: 13.13 g in 133.1 mL
Code: DE08037SABClass: ACTIBQuantity: 1.2 g in 133.1 mL

SUPREP Bowel Prep

Product Details

NDC Product Code
52268-012
Application Number
NDA022372
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
August 18, 2020
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4Class: IACT
MALIC ACIDInactive
Code: 817L1N4CKPClass: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
Code: 0YPR65R21JClass: ACTIBQuantity: 17.5 g in 1 mL
Code: 1K573LC5TVClass: ACTIBQuantity: 3.13 g in 1 mL
Code: DE08037SABClass: ACTIBQuantity: 1.6 g in 1 mL
© Copyright 2025. All Rights Reserved by MedPath